Voyageur Pharmaceuticals (CVE:VM) Stock Price Up 28.6% – Should You Buy?

Shares of Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) shot up 28.6% during mid-day trading on Monday . The stock traded as high as C$0.21 and last traded at C$0.18. 1,188,155 shares traded hands during mid-day trading, an increase of 253% from the average session volume of 336,778 shares. The stock had previously closed at C$0.14.

Voyageur Pharmaceuticals Price Performance

The stock’s 50-day simple moving average is C$0.08 and its 200 day simple moving average is C$0.06. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21. The firm has a market cap of C$18.83 million, a P/E ratio of -13.50 and a beta of 0.32.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Further Reading

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.